As of early May 2026, the CDC has confirmed roughly 1,840 measles cases across 39 U.S. jurisdictions, with 93 percent tied to outbreaks that began in late 2025 or early this year. Sustained community transmission in under-vaccinated populations, especially children and adolescents in states such as Utah, Texas, and Arizona, continues to drive new infections, fueled by imported cases from international travel. The virus’s high contagiousness (R0 of 12–18) allows rapid spread when MMR vaccination coverage falls below the 95 percent herd-immunity threshold. Weekly CDC surveillance updates, summer travel peaks, and any state-level vaccination campaigns or school-entry policy changes represent the next key data points that could shift total 2026 counts before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoPrzypadki odry w USA w 2026 roku?
Przypadki odry w USA w 2026 roku?
$7,668,426 Wol.
$7,668,426 Wol.
Dec 31, 2026
↑2k
99%
↑3k
62%
↑4k
27%
↑5k
16%
↑7,5 tys.
16%
↑10k
9%
↑12,5 tys.
5%
$7,668,426 Wol.
$7,668,426 Wol.
Dec 31, 2026
↑2k
$45,433 Wol.
99%
↑3k
$50,215 Wol.
62%
↑4k
$170,658 Wol.
27%
↑5k
$215,323 Wol.
16%
↑7,5 tys.
$174,218 Wol.
16%
↑10k
$6,492,969 Wol.
9%
↑12,5 tys.
$344,846 Wol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed roughly 1,840 measles cases across 39 U.S. jurisdictions, with 93 percent tied to outbreaks that began in late 2025 or early this year. Sustained community transmission in under-vaccinated populations, especially children and adolescents in states such as Utah, Texas, and Arizona, continues to drive new infections, fueled by imported cases from international travel. The virus’s high contagiousness (R0 of 12–18) allows rapid spread when MMR vaccination coverage falls below the 95 percent herd-immunity threshold. Weekly CDC surveillance updates, summer travel peaks, and any state-level vaccination campaigns or school-entry policy changes represent the next key data points that could shift total 2026 counts before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Rynek otwarty: Dec 1, 2025, 12:56 PM ET
Wolumen
$7,668,426Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early May 2026, the CDC has confirmed roughly 1,840 measles cases across 39 U.S. jurisdictions, with 93 percent tied to outbreaks that began in late 2025 or early this year. Sustained community transmission in under-vaccinated populations, especially children and adolescents in states such as Utah, Texas, and Arizona, continues to drive new infections, fueled by imported cases from international travel. The virus’s high contagiousness (R0 of 12–18) allows rapid spread when MMR vaccination coverage falls below the 95 percent herd-immunity threshold. Weekly CDC surveillance updates, summer travel peaks, and any state-level vaccination campaigns or school-entry policy changes represent the next key data points that could shift total 2026 counts before year-end resolution.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Wolumen
$7,668,426Data zakończenia
Dec 31, 2026Rynek otwarty
Dec 1, 2025, 12:56 PM ETResolver
0x65070BE91...As of early May 2026, the CDC has confirmed roughly 1,840 measles cases across 39 U.S. jurisdictions, with 93 percent tied to outbreaks that began in late 2025 or early this year. Sustained community transmission in under-vaccinated populations, especially children and adolescents in states such as Utah, Texas, and Arizona, continues to drive new infections, fueled by imported cases from international travel. The virus’s high contagiousness (R0 of 12–18) allows rapid spread when MMR vaccination coverage falls below the 95 percent herd-immunity threshold. Weekly CDC surveillance updates, summer travel peaks, and any state-level vaccination campaigns or school-entry policy changes represent the next key data points that could shift total 2026 counts before year-end resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania